Nurses will learn how to recognize risks like hypoglycemia with sulfonylureas, genitourinary infections with SGLT2 inhibitors, and gastrointestinal effects with GLP-1 agents, along with key patient counseling points
Many advanced chargers use a combination of both methods, which is fine as they monitor the battery during charging
For instance, 15.8% of people taking a 0.5 mg injection experienced nausea, compared to 20.3% of people taking a 1.0 mg injection in clinical trials
Cysteamine-colon and cysteamine-duodenum lesions in rats
*Valid for appointments scheduled with select providers (Alison, Tom, or Stephanie)
Pancreatitis-imaging approach